Actively Recruiting
Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging
Led by Anna Raciborska · Updated on 2026-03-25
150
Participants Needed
1
Research Sites
325 weeks
Total Duration
On this page
Sponsors
A
Anna Raciborska
Lead Sponsor
M
Maria Sklodowska-Curie National Research Institute of Oncology
Collaborating Sponsor
AI-Summary
What this Trial Is About
Prospective, low intervention, open, single-center, non-commercial clinical trial to improve diagnostics in patients with histiocytosis by assessing the molecular profile of the tumor tissues, monitoring its presence in free-circulating DNA, and determining the efficacy of fluorodeoxyglucose (18F-FDG) in PET-CT imaging.
CONDITIONS
Official Title
Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient under 18 years of age at the time of inclusion.
- Histopathologically confirmed or suspected histiocytosis based on prior test results.
- Signing of informed consent for trial participation according to current legal regulations.
You will not qualify if you...
- Lack of inclusion criteria.
- Pregnancy.
- Other acute or persistent disorders, behaviors, or abnormal laboratory test results that might increase risk, affect study results, or disqualify participation according to the investigator's opinion.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mother and Child Institute
Warsaw, Mazovian, Poland, 01-211
Actively Recruiting
Research Team
K
Katarzyna Maleszewska
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here